
Tecovirimat (ST-246), cidofovir, and brincidofovir (CMX001) are the antiviral agents currently used to treat mpox. The currently circulating mpox viruses (MPXVs) have genomic alterations that were not observed previously and appear to affect virus biology, as indicated by the clinical and epidemiologic features seen with the viruses in the current outbreak, which are different from those seen in previous mpox outbreaks. These alterations may also affect virus sensitivity to antiviral drugs.
Like
Save
Share